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Bovine papillomavirus type 1 (BPV-1) DNA replicates episomally and requires two virally expressed
proteins, El and E2, for this process. Both proteins bind to the BPV-1 genome in the region that functions as
the origin of replication. The binding sequences for the E2 protein have been characterized previously, but little
is known about critical sequence requirements for El binding. Using a bacterially expressed El fusion protein,
we examined binding of the BPV-1 El protein to the origin region. El strongly protected a 28-bp segment of
the origin (nucleotides 7932 to 15) from both DNase I and exonuclease III digestion. Additional exonuclease
III protection was observed beyond the core region on both the 5' and 3' sides, suggesting that El interacted
with more distal sequences as well. Within the 28-bp protected core, there were two overlapping imperfect
inverted repeats (IR), one of 27 bp and one of 18 bp. We show that sequences within the smaller, 18-bp IR
element were sufficient for specific recognition of DNA by El and that additional BPV-1 sequences beyond the
18-bp IR element did not significantly increase origin binding by El protein. While the 18-bp IR element
contained sequences sufficient for specific binding by El, El did not form a stable complex with just the
isolated 18-bp element. Formation of a detectable El-DNA complex required that the 18-bp IR be flanked by
additional DNA sequences. Furthermore, binding of El to DNA containing the 18-bp IR increased as a function
of overall increasing fragment length. We conclude that El-DNA interactions outside the boundaries of the
18-bp IR are important for thermodynamic stabilization of the El-DNA complex. However, since the flanking
sequences need not be derived from BPV-1, these distal El-DNA interactions are not sequence specific.
Comparison of the 18-bp IR from BPV-1 with the corresponding region from other papillomaviruses revealed
a symmetric conserved consensus sequence, T-RY--TTAA--RY-A, that may reflect the specific nucleotides
critical for El-DNA recognition.
Bovine papillomavirus type 1 (BPV-1) is a member of the
papovavirus family and is the prototype virus for the papillo-
mavirus subgroup. The BPV-1 genome can be taken from its
natural host and will replicate, in both stable and transient
replication assays (13-15, 27), in a variety of animal cell lines
including C127 and NIH 3T3 cells (8, 12, 14, 27, 32). The
7,945-bp viral genomic DNA is preserved in these cells as an
extrachromosomal entity at a constant copy number of 50 to
200 molecules per cell (8). Because of its limited genomic
coding capacity, BPV-1 requires cellular host DNA replication
factors and enzymes for its replication. This dependence on the
host cell replication machinery makes BPV-1 a useful model
for general studies of cellular replication mechanisms and
control. However, a necessary first step will be the careful
definition of viral cis and trans replication elements.
Two viral proteins are unequivocally required for transient
replication of the viral DNA, the full-length El open reading
frame protein and the full-length E2 open reading frame
protein, E2TA (27). El was first shown to be a site-specific
DNA-binding protein with a bacterially expressed El-related
fusion protein termed RecA-El (30). RecA-El binds specifi-
cally to a 219-bp BPV-1 fragment spanning nucleotides 7819 to
93. Cleavage of this fragment at the unique HpaI site elimi-
nates El binding, indicating that the El binding site is located
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at or near the HpaI site (30). Subsequent studies showed that
El protein expressed in either prokaryotic or eukaryotic cells
protects the HpaI region from DNase I digestion (28, 33). In
addition, small deletions or insertions at the HpaI site greatly
reduced El binding (23, 34). Together, these studies establish
that there is a prominent El binding site in the vicinity of the
unique HpaI site, but they do not specifically define critical
sequences for binding.
Recently, the approximate boundaries of the functional
BPV-1 origin of replication were defined both in vivo and in
vitro (see Fig. 2) (28, 33). The functional origin encompasses
the El binding region, which is consistent with a direct role for
El in replication initiation via binding to origin DNA se-
quences. In addition to an El binding site, the BPV-1 origin of
replication also contains an AT-rich region and an E2 DNA
binding site (10, 26, 28). Ustav et al. have shown that an E2
binding site is strictly required for BPV-1 replication in vivo
(26). The 48-kDa E2TA protein is a well-characterized DNA
binding protein that is the major viral transcriptional activator
(22, 24); however, the E2 transactivation function is not
required for its function in DNA replication (1, 32). The role
of E2 in replication appears to be related to its ability to form
protein-protein complexes with El (2, 16, 17) and to enhance
the binding of El to DNA (20, 33). Presumably, El-E2
protein-protein interactions, along with El-DNA interactions,
are important for formation of the El replication complex at
the origin.
The El protein shares both sequence and functional homol-
ogy with simian virus 40 (SV40) large T antigen (4, 19); both
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proteins are absolutely required for replication of their respec-
tive genomes, are located predominantly in the nucleus (6, 9),
are origin-binding proteins (6, 21, 28, 30), have DNA helicase
(6, 21) and origin-unwinding activity (6, 20, 21), and have
DNA-dependent ATPase activity (21). T antigen binds a 27-bp
palindromic sequence at the SV40 origin and assembles into a
multimeric complex that orchestrates the initial unwinding of
the SV40 origin (5, 6). Given the similarities between T antigen
and El, it is likely that El also functions in a complex fashion
to promote initiation of BPV-1 replication. In this paper, we
show that El binding specificity is contained within an 18-bp
inverted repeat (IR) element that includes the unique HpaI
site at the origin of replication. However, while specificity
resides within the 18-bp IR, formation of a stable El-DNA
complex requires additional nonspecific flanking sequences.
MATERIALS AND METHODS
Exonuclease III protection assay. RecA-E1 was immunopre-
cipitated with anti-El249 serum (31) and protein A-Sepharose
(Pharmacia) as previously described (30). The washed immu-
nocomplex was resuspended in 20 ,ul of 0.05 M TNE (10 mM
Tris-HCl, 50 mM NaCl, 0.1 mM EDTA, pH 7.0) containing 50
ng of a 214-bp single end-labeled DNA. This double-stranded
DNA substrate was produced by PCR amplification of pd-
BPV-1 DNA with primers whose 5' ends were at BPV-1
nucleotides 7830 and 99, respectively. DNA was labeled on the
5' end of either the upper or the lower strand by phosphory-
lating the appropriate primer with [_y-32P]ATP prior to the
PCR. The labeled DNA was incubated with the immunocom-
plex for 30 min at 25°C, and then the complex was washed
twice with exonuclease III buffer (66 mM Tris-HCl, 0.66 mM
MgCl2, 1 mM 2-mercaptoethanol, pH 7.6), resuspended in 10
,u of exonuclease III buffer containing from 0 to 10 U of
exonuclease III (Boehringer Mannheim), and incubated for 5
min at 37°C. Control extracts lacking RecA-El were similarly
immunoprecipitated and washed except that there was no
incubation step with labeled DNA. For the control samples,
the immunoprecipitates were supplemented with an amount of
labeled DNA comparable to that bound in the RecA-El
immunoprecipitates. For both RecA-El and control samples,
exonuclease III digestion was stopped by addition of 4 [lI of
sequencing sample buffer (95% [vol/vol] formamide, 10 mM
EDTA, 0.1% bromophenol blue, 0.1% xylene cyanol) followed
immediately by 5 min at 95°C. Samples were analyzed directly
on standard 6% sequencing gels.
Purification and labeling of oligos. Synthetic oligonucleo-
tides (oligos) corresponding to the upper and lower strands of
the two IR sequences in the BPV-1 origin of replication were
constructed (see Fig. 3): 5'ATTGTTGTTAACAATAAT3'
(18-mer upper) and 5'ATTATTGTTAACAACAAT3' (18-
mer lower), and 5'CAGTGAATAATTGTTGTTAACAATA
ATCACAC3' (32-mer upper) and 5'GTGTGATTATTGTT
AACAACAATTATTCACTG3' (32-mer lower). Oligos were
electrophoresed on a denaturing Tris-borate 12% polyacryl-
amide gel and were purified with the MERmaid kit (Bio 101).
Purified oligos were quantitated by spectrophotometry.
Each oligo (100 ng) was end labeled with T4 polynucleotide
kinase, kinase buffer (60 mM Tris-HCl [pH 7.8], 10 mM
MgCl2, 200 mM KCl), and [y-32P]ATP at 370C for 1 h. This
reaction was chased with 50 ,uM cold ATP for 30 min to ensure
labeling of all oligo ends. Complementary labeled oligos (50
ng) were incubated at 68°C for 10 min and then slowly cooled
to 4°C for 10 to 12 h to give efficient annealing. Annealed
oligos (1 to 2 ng) were ligated with T4 DNA ligase at 40C for
12 to 16 h. Labeled oligos (0.1 to 0.4 ng) were used in the DNA
binding assay (below) in either single-stranded, double-
stranded, or ligated forms.
Cloning oligos. The double-stranded 18-mer sequence was
cloned into the SmaI site of the pUC18 polylinker. Potential
positive clones were sequenced with the dsDNA Cycle Se-
quencing System as recommended by the manufacturer (BRL
Life Technologies, Inc.). A positive clone containing a single
copy of the double-stranded 18-mer sequence was designated
pUC18/18-mer. The double-stranded 32-mer was cloned in the
same manner and named pUC32-mer. A 105-bpAluI fragment
of BPV-1 DNA (nucleotides 7892 to 52) was cloned into the
SmaI site of pUC18 and designated ORI-105.
Digestion and labeling of cloned oligos. The pUC18/18-mer
clone was PCR amplified by standard methods to generate a
169-bp fragment. This 169-bp segment (0.5 to 1.0 ,ug) was
digested with four combinations of restriction enzymes: EcoRI
and SalI, EcoRI and BamHI, Sall and Acc65I, or BamHI and
Acc65I. The 5' overhangs of these DNA pieces were made
blunt and radiolabeled by incubation at room temperature for
10 to 20 min with 1 U of Sequenase 2.0 (United States
Biochemical Corporation); 7.5 ,uM (each) dATP, dCTP, and
dGTP; 0.3 ,uM [a-32P]TTP (ICN, Inc.); 40 mM Tris-HCl (pH
7.5); 20 mM MgCl2; and 50 mM NaCl. The reaction was
terminated by being heated to 70°C for 10 min. Each labeled
fragment (10 to 20 ng) was used in the DNA binding assay
described below.
For some experiments, the pUC clones containing the
18-mer sequence, the 32-mer sequence, or the ORI-105 se-
quence of BPV-1 were generated by incorporation of labeled
[a-32P]TTP during PCR amplification of the appropriate
clones. The resultant fragments (256, 270, and 256 bp, respec-
tively) had the same specific activity and were used directly for
DNA binding assays.
DNA binding assays. Bacterial extracts with and without the
RecA-El protein were prepared as previously described (30).
DNA binding assays with the oligos were performed as previ-
ously described (30) with some modifications. For ligated
oligomers, labeled DNA was incubated with the bacterial
extract and sheared salmon sperm DNA in 10 mM TNE (10
mM Tris HCl [pH 7.0], 10 mM NaCl, 0.01 mM EDTA). After
incubation, El-DNA complexes were immunoprecipitated and
washed as before. The washed immunoprecipitates were incu-
bated with 10 ,ul of TBE sample buffer (89 mM Tris, 89 mM
boric acid, 2.5 mM EDTA, 10% glycerol, 2.7% xylene cyanol,
2.4% bromophenol blue, 1.5% sodium dodecyl sulfate) for 1 h
at 370C to extract bound labeled DNA. Supernatants were
electrophoresed on nondenaturing Tris-borate 15% polyacryl-
amide gels. Gels were dried and exposed to X-ray film for
autoradiography with an intensifier screen.
The DNA binding assay for single-stranded oligos, mono-
meric double-stranded oligos, and PCR products of pUC18/
18-mer, pUC32-mer, and ORI-105 was altered slightly. Briefly,
10 [lI of bacterial extract was immunoprecipitated (without any
DNA) with anti-El antibodies as described previously (30).
These samples were then incubated at 25°C for 30 min with
1,500 ng of unlabeled sheared salmon sperm DNA, 150 mM
TNE (10 mM Tris HCI [pH 7.0], 150 mM NaCl, 0.01 mM
EDTA), and labeled cloned oligo fragments (quantities given
above). The samples were washed three times with 1 ml of 10
mM TNE supplemented with 200 mM NaCl, 0.25% Nonidet
P-40, and 5 ,ug of sheared salmon sperm DNA. A final wash
was done with 1 ml of 10 mM TNE. Washed pellets were
incubated with 15 or 60 ,ug of proteinase K for 30 min at 550C,
and then the labeled DNA was extracted with TBE sample
buffer as described above. The extracted DNA was electro-
phoresed on nondenaturing Tris-borate 8, 10, or 15% poly-
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acrylamide gels. Gels were dried and autoradiographed as
described above. The relative amounts of bound DNA frag-
ments were quantitated by densitometric analysis of the auto-
radiographs with the IS-100l Digital Imaging System (Inno-
tech Scientific Corp.).
Construction of deletion mutants. Purified pdBPV-1
(ATCC 37134) DNA was linearized at the unique HpaI site
and gel purified. Linearized DNA (5 p.g) was treated with 0.5
U of Bal 31 (International Biotechnologies, Inc.) at 30°C. At
30-s intervals after addition of Bal 31, 1-pLg samples were
removed and Bal 31 digestion was terminated by addition of 1
volume of 0.2 M EDTA followed by phenol-chloroform extrac-
tion. Each 1-,ug sample of Bal 31-treated DNA was concen-
trated with the Prep-A-Gene system (Bio-Rad) and self-ligated
for 30 min at 16°C with 0.5 U of T4 DNA ligase (Boehringer
Mannheim). After 30 min of ligation, the reactions were
digested for 30 min at 37°C with 2 U of HpaI (Boehringer
Mannheim). The resultant DNA was used to transform Esch-
erichia coli TB1 cells, and clones were screened for the absence
of a HpaI site. HpaI site-minus clones were sequenced directly
from colonies with the dsDNA Cycle Sequencing System
(GIBCO BRL). A deletion mutant lacking 8 bp to the 5' side
of the HpaI cleavage site was designated A5', while a similar
mutant lacking 8 bp on the 3' side of the HpaI site was
designated A3'. Binding studies with the deletion mutant DNA
were performed as previously described (30).
RESULTS
El protein protects an extended region of BPV-1 DNA from
nucleases. Our previous study demonstrated that a bacterially
expressed El protein (RecA-EI) is a site-specific DNA-bind-
ing protein. Strong binding of RecA-El to the BPV-1 genome
was observed only in the vicinity of the unique HpaI site on the
BPV-1 genome (30). The HpaI region is now known to be the
functional origin of replication (28, 33), suggesting that the
interaction of El with sequences in this region will be critical
for the replication process. Subsequent DNase I footprinting
with the RecA-El protein showed a clearly delimited 28-bp
protected region from nucleotides 7932 to 15 on the lower
strand, a region which encompassed the HpaI site (29). Pro-
tection of this region was also observed on the upper strand,
though the protection was less pronounced and extended
further in both the 5' and 3' directions. Similar extended
DNase I protection has been reported previously, confirming
the general location of the El binding site on the BPV-1
genome (28, 33).
Since the boundaries of El protection on the upper strand
were difficult to define precisely by DNase I footprinting, we
performed exonuclease III footprinting of RecA-EI bound to
an origin-containing fragment (Fig. 1). The exonuclease III
experiments were performed under the same conditions and at
the same protein/DNA ratio used for McKay assays (30) (see
Fig. 4 to 7) and presumably reflect similar El-DNA interac-
tions. On both the upper and lower strands, there were
multiple clusters of exonuclease III stop sites, with some stop
sites being more prominent than others. Only the exonuclease
III stops that were consistently observed are marked in Fig.1.
The most distal stop sites were at nucleotide positions 25 to 28
on the upper strand and 7900 to 7903 on the lower strand. The
boundaries of the protected region defined by the most distal
stop sites spanned 74 bp and encompassed the region seen
protected by DNaseI. However, the most prominent lower-
and upper-strand exonuclease III stops (positions 7932/33 and
15) corresponded exactly to the 28-bp DNase I-protected
region seen on the lower strand (Fig. 2). This concordance
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FIG. 1. Exonuclease III footprints of RecA-EI bound to the BPV-1
origin region. Exonuclease III footprinting was performed on immu-
noprecipitated El-DNA complexes as described in Materials and
Methods. Footprinting reactions contained DNA labeled on the 5' end
of the lower strand (A) or the upper strand (B). Lanes without El
contained immunoprecipitates of control extracts which were supple-
mented after precipitation with amounts of free labeled DNA compa-
rable to the El precipitates. Lanes marked A contained an A
sequencing reaction of the DNA used as the El binding substrate.
Exonuclease stop sites that were reproducibly present in El bound
samples are marked with braces or arrows, and the BPV- 1 nucleotide
numbers of the stop positions are given.
between the DNase I and exonuclease III footprints suggested
that the primary binding site for El was located between
positions 7932 and 15 on the genome map. The more distal
exonuclease III stop sites were consistent with additional
El-DNA interactions that extended beyond the primary bind-
ing site at the protein/DNA ratio employed for these experi-
ments. These more distal exonuclease III stop sites were
asymmetric with respect to the central protected region;
exonuclease III stops extended further to the 5' side than to
the 3' side. The significance of this asymmetry is unknown.
As previously noted (28), the nucleotide sequence in the
central El-protected region (nucleotides 7932 to 15) contains
alternative imperfect IR elements (Fig. 3). The smaller ele-
ment is an 18-bp IR from nucleotides 7940 to 12, with a dyad
axis between nucleotides 4 and 5. There is a single mismatched
pair in this IR with a G at nucleotide 7943 in the 5' half and a
corresponding T at nucleotide 9 in the 3' half. The larger IR
J. VIROL.
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AT Rich DNase Footprint E2 Site
7932 15
01111 111111 lil
OAGCTCACCGAAACCGGTAAGTAAAGACTAT GTAT T TTTTCCCAGTGAATAAT TGTTGTTAACAATAATCACACCATCACCGTT T TTTCAAGCGGGAAAAAA
TCGAGTGGCTTTGGCCAT TCAT T T CTGATACATAAAAAAGGGTCACTTATTAACAACAATTGTTATTAGTGTGGTAGTGGCAAAAAAGT TCGCCCTTTTTT
titt ttlt tt
7911 22
In Vitro Functional Origin
7916 27
In Vivo Functionat Origin
FIG. 2. Summary of DNase I and exonuclease III footprinting results. Shown are the upper and lower strands of the BPV-1 genome from
nucleotides 7890 to 45. Brackets above the sequence indicate the positions of an AT-rich region, the region on the lower strand protected from
DNase I digestion by RecA-El, and a binding site for E2 protein. Brackets below the sequence indicate the location of DNA fragments that
function as an origin of replication in vitro (33) and in vivo (28). Arrows indicate the positions of exonuclease III stop sites on the upper and lower
strands. Larger arrows indicate the predominant stop sites.
element has a 13-bp 5' segment and a 12-bp 3' segment; the 5'
and 3' portions are separated by a 3-bp sequence (GTT). As
many DNA-binding proteins recognize sequences with dyad
symmetry, the presence of the alternative IR elements sug-
gested that one or both might be important for El binding.
However, since both IRs were overlapping and entirely con-
tained within the predominant El-protected region, the signif-
icance of either IR for El binding specificity could not be
deduced from the footprinting data.
El binding specificity resides within an 18-bp IR element.
To further describe RecA-El binding site sequence require-
ments, two sets of oligos which corresponded to the two
alternative IR elements within the RecA-El-protected region
were constructed. A set of 32-base oligos (upper and lower
strands) was composed of BPV-1 sequences 7931 through 17,
and contained the A'/B' IR shown in Fig. 3. The second set
consisted of 18-base oligos spanning the A/B IR. Each oligo
was end labeled and used in single-stranded, double-stranded,
and ligated forms as a substrate for RecA-El binding in the
immunoprecipitation assay (Fig. 4). None of the single-
stranded oligos was bound by RecA-El in this assay (data not
shown). In addition, the monomeric, double-stranded forms of
the 18-mer and 32-mer oligos were not efficiently bound by
RecA-El under these conditions; no binding to the 18-mer was
observed, and only minimal binding to the 32-mer was detected
(Fig. 4A, lane 4; Fig. 4B, lane 2). However, the RecA-El
RecA-El Protected Region
A B
C A G T G A A T A|A T T G T T G T T|A A C A A T A A TIC A C A C C
7931 18
C AIG T G A A T A A T T G T T|G T TA A C A A T A A T C ACAA C C
A' B'
FIG. 3. Alternative IRs in the El binding region. The upper strand
of the BPV-1 DNA sequence from nucleotides 7931 to 18 is shown
twice. Boxes on these sequences indicate the locations of an 18-bp IR
(AB) and a 13/12-bp IR (A'B'). The bracket above the sequence
indicates the boundaries of the predominant region protected from
DNase I digestion by bound RecA-El.
protein effectively bound the ligated forms of both the 18-mer
and the 32-mer (Fig. 4A, lane 6; Fig. 4B, lane 5). No binding to
these ligated oligos was detected with extracts lacking
RecA-El ("IP*" lanes) or when the immunoprecipitations
were performed with preimmune serum ("pl" lanes), confirm-
ing that the precipitation of these ligated oligos was El
dependent. Furthermore, binding to the ligated BPV-1 oligos
was sequence specific as no El-specific binding was detected to
either of two control oligos (an 8-bp HindIII linker or an 18-bp
AT-rich oligo) in monomeric, double-stranded form (not
shown) or after self-ligation (Fig. 4C). Note that the AT-rich
oligo consisted of an 18-bp IR sequence with an AT content
similar to that of the BPV-1 origin 18-mer and yet still failed to
bind El. Consequently, the observed binding of RecA-El to
the ligated BPV-1 oligos was not simply a function of nonspe-
cific binding to larger-size or AT-rich DNA, but reflected a
true sequence specificity. The ability of RecA-El to bind the
ligated 18-mer indicated that sequences contained within the
18-bp IR were sufficient to confer specific recognition and
binding by El.
To further confirm the specificity of the El fusion protein
for these oligos, a competition assay was performed. Purified
pdBPV-1 plasmid DNA was digested with Avall and radiola-
beled as previously described (30). Among the fragments
generated was a 219-bp fragment that contained the El
binding site and the BPV-1 origin of replication. Using the
same immunoprecipitation conditions described above, bacte-
rial extracts containing RecA-El were incubated with the
radiolabeled pdBPV-1 fragments and increasing amounts of
the unlabeled oligos in the double-stranded monomeric form
or in the ligated form. The monomeric forms of each oligo
showed little or no competition with the 219-bp fragment for
El binding (data not shown). However, the ligated forms of
both the 18-mer and the 32-mer competed effectively with the
labeled 219-bp fragment for binding by RecA-El (data not-
shown). No competition was observed with the monomer or
ligated form of the HindIlI linker. The ability of the ligated
18-mer to compete with the authentic El binding site con-
firmed that sequences within the 18-bp IR were sufficient for
DNA recognition by RecA-El protein.
The failure of the monomeric forms of either the 32-mer or
18-mer to compete with the 219-bp fragment suggested that
while specificity was inherent in the 18-bp IR, the affinity of El
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FIG. 4. Binding of RecA-El to oligos that correspond to alternative IR elements. The immunoprecipitation binding assay was performed with
either the 18-bp BPV-1 IR oligo (A), the 32-bp IR oligo (B), a control HindlIl linker (C), or a control AT-rich oligo (C) as the DNA substrate.
Oligos were in either monomeric double-stranded ("ds" lanes) or ligated ("lig ds" lanes) forms as indicated. Precipitations were performed with
extracts containing RecA-El ("IP" lanes) or control extracts lacking RecA-El ("IP*" lanes). All precipitations used anti-El serum except lanes
marked "pl," which used preimmune serum. For monomeric double-stranded DNA samples, El protein was first immunoprecipitated and then
incubated with the DNA substrates. Oligomeric substrates were mixed directly with the El extracts, and the El-DNA complexes were
coprecipitated. Lanes without the "IP" designation were marker lanes showing the oligos used as substrates for the binding reactions.
binding to short pieces of DNA was poor. One possible
explanation for this was that stable binding of El required the
18-bp recognition element in the context of additional nonspe-
cific DNA sequence. Presumably, these additional nonspecific
sequences would contribute to the thermodynamic stabiliza-
tion of the El-DNA complex such as that observed for the
bacterial catabolite gene activator protein (11). This also
would be consistent with the footprinting results which indi-
cated a significant El-DNA interaction beyond the boundaries
of the 18-bp IR.
To test this hypothesis, both the double-stranded 18-mer
and the 32-mer were cloned into pUC18 and the resulting
constructs were designated pUC18/18-mer and pUC32-mer,
respectively. PCR-amplified pUC18/18-mer or pUC32-mer
DNA was digested with four pairs of restriction endonucleases
to generate fragments with BPV-1 sequences flanked by vari-
ous lengths of nonspecific DNA. The digestions also released
similar-size plasmid-derived fragments lacking BPV-1 se-
quence which served as internal specificity controls. The
fragment mixtures were radiolabeled with a DNA polymerase
fill-in reaction and then tested for binding to RecA-E1 by the
immunoprecipitation procedure. The results for the cloned
18-mer are shown in Fig. 5, and similar results were obtained
for the cloned 32-mer (not shown). In all cases, the fragments
containing the 18-mer sequence were specifically bound by
RecA-El (Fig. 5A). No binding was detected to plasmid-
derived fragments lacking the 18-mer sequences, once again
confirming that the 18-bp IR element was sufficient to confer
El binding specificity. While no binding was observed for the
monomeric 18-mer (Fig. 4), binding could be detected to the
cloned 18-mer within a fragment of overall length of 31 bp
(Fig. 5A). It was also observed that the relative binding by
RecA-El increased with increasing fragment size (Fig. 5B).
The El protein showed approximately threefold-greater bind-
ing to a 55-bp fragment than to the 31-bp fragment, while the
two 43-bp fragments showed intermediate levels of El binding.
As these four fragments differed only in the length of their
non-BPV-1 flanking sequences, this was consistent with our
hypothesis that El-DNA contacts outside the 18-bp element
helped stabilize the complex. In addition, comparison of El
binding with the two 43-bp fragments versus the 31-bp frag-
ment indicated that binding was improved by addition of
nonspecific sequences onto either the 5' or 3' ends of the 18-bp
IR. Together, the binding studies with the oligos and the
cloned 18-mer suggest that a sequence length somewhere
between 18 and 31 bp is necessary in order to detect binding of
RecA-El in the immunoprecipitation assay.
Comparison of binding to the 18-mer and 32-mer in the
absence of fragment length effects. The studies described
above indicated that sequences within the 18-mer were suffi-
cient to direct specific binding of the El protein. However,
these studies did not rule out the possibility that additional
BPV-1 sequences flanking the 18-mer region might contribute
to an increased affinity of El for BPV-1 DNA. To address this
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FIG. 5. Binding of the RecA-El protein to the cloned 18-bp IR.
Panel A shows the binding of RecA-El to pUC18/18-mer cleaved with
four pairs of restriction endonucleases. The region of pUC18/18-mer
containing the cloned BPV-1 18-mer was PCR amplified, and the
resultant 169-bp fragment was cleaved with EcoRI and Sall (E/S),
EcoRI and BamHI (E/B), Sall and Acc65I (S/A), or BamHI and
Acc65I (B/A). The fragments were labeled by filling in the overhanging
ends and then used for the immunoprecipitation binding assay. Lanes
marked "IP" indicate immunoprecipitations performed with extracts
containing RecA-El, while the "IP*" lane was immunoprecipitated
with extracts lacking RecA-El. Lanes without the "IP" designation
were marker lanes showing the labeled fragment pattern from each
digestion. For each digestion, the 18-mer-containing fragment was the
smallest fragment in each lane. Other fragments were derived from
vector sequences and served as internal specificity controls. Panel B
summarizes the results found in panel A. Shown are the sizes and
sequences of the pUC18/18-mer-derived fragments which contain the
18-bp IR and the relative binding of RecA-El protein to each
fragment. Binding was normalized to the 55-bp fragment and repre-
sents an average of two experiments.
question in the absence of confounding effects due to differ-
ences in the overall length of flanking sequences, binding of El
to the 18-mer and the 32-mer sequences was examined with
each sequence embedded within a much larger fragment
(256-bp overall length for the 18-mer and 270 bp for the
32-mer). El binding to the 18-mer- and 32-mer-containing
fragments was compared relative to binding to a similar-size
fragment, designated ORI-105. The ORI-105 fragment was
256 bp in length and contained 105 bp of BPV-1 DNA,
including the entire functional origin region, along with addi-
tional adjacent BPV-1 sequences. As the ORI-105 fragment
contained BPV-1 sequences including and beyond the bound-
aries of the most distal El-protected regions detected by
0 20 40 60 80
Percent Binding
100 120 14C
FIG. 6. Comparative binding of RecA-El to cloned 18-mer and
32-mer sequences in the context of a large DNA fragment. PCR-
amplified fragments of pUCI8/18-mer (256 bp), pUC32-mer (270 bp),
or a cloned 105-bp BPV-l origin fragment (ORI-105; 256 bp) were
assayed for El binding (upper bands in panel A). A 211-bp PCR-
amplified fragment containing the same BPV-l sequences as ORI-105
was included in each binding reaction as an internal control for sample
handling and recovery (lower bands in panel A). Binding was assayed
as described in Materials and Methods, and panel A shows a typical
binding experiment. To quantitate relative binding, the ratio of the
amount of bound large and small fragments was determined for each
sample. The ratio for the large to small fragments derived from the
ORI-105 clone was set at 100, and the corresponding ratios for the
pUC18/18-mer and pUC32-mer samples were normalized relative to
this value. Panel B shows the average relative binding determined in
three replicate experiments.
exonuclease III footprinting, it was presumed to contain all the
necessary cis information for El origin binding and thus served
as the wild-type substrate. Figure 6 shows a representative
binding assay (panel A) and the average binding to the 18-mer
and 32-mer sequences relative to ORI-105 (panel B). The
256-bp pUC18/18-mer fragment bound nearly as well as the
256-bp ORI-105 fragment, indicating that BPV-1 sequences
outside the 18-bp IR did not dramatically influence El-DNA
interactions. In this series of experiments, the pUC32-mer
fragment consistently bound somewhat better than the ORI-
105 fragment. It is possible that the conjunction of the 32-mer
sequences with vector sequences in this fragment creates a
slightly more favorable environment for El binding than when
the 32-mer sequences are in their normal BPV-1 context.
Nonetheless, the results from this experiment indicate that
sequences unique to the 32-mer do not greatly enhance El
binding in comparison with the 18-mer.
Both halves of the 18-bp IR are critical for El binding. To
examine the contribution of each half-site of the 18-bp IR to
El binding, deletion mutations were constructed in either the
5' or 3' halves of the IR element (Fig. 7A). Removal of either
half-site drastically reduced binding of RecA-El to the origin
region (Fig. 7B). Densitometric quantitation of a longer expo-
sure indicated that binding to the 5' or 3' deletion DNA was I
to 3% of binding to the undeleted parental DNA. Identical
results were obtained for binding of RecA-EI to either the 5'
or the 3' half-sites cloned into pUC18; the presence of either
A.
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FIG. 7. Binding of RecA-El to half-site deletion mutants. Panel A
shows the origin region sequences of wild-type BPV-1 and two deletion
mutants. Panel B shows the binding of RecA-E1 to the wild-type and
mutant DNAs. Lanes marked with an asterisk contained a sample of
the labeled input DNA used in the binding reactions. Substrate DNA
was produced by PCR amplification of the BPV-1 origin region from
nucleotides 7830 to 99. The resultant fragment (214 bp for wild-type;
206 bp for the deletion mutants) was labeled by AvaIl digestion
followed by end repair with T7 DNA polymerase and [32P]dCTP. One
nanogram of labeled wild-type or mutant DNA was incubated with
extracts containing (+ lanes) or lacking (- lanes) RecA-El and then
immunoprecipitated with anti-El serum as described in Materials and
Methods.
half-site in a pUC18 fragment was insufficient to direct specific
binding by RecA-El (7). For both the deletion mutants and the
cloned half-sites, the BPV-1-derived sequences were contained
within a larger DNA fragment for the binding assay. Conse-
quently, failure to bind was not due to a lack of nonspecific
protein-DNA contacts. We conclude from these studies that
the presence of sequences in both halves of the 18-bp IR was
critical for the formation of a stable El-DNA complex.
Identification of a consensus homology between the BPV-1
El binding site and comparable regions in other papillomavi-
ruses. It has recently been shown that heterologous combina-
tions of El and E2 proteins can support replication from
papillomavirus origins of several species and subtypes (3). This
functional interchangeability implies that origins from various
papillomaviruses will show sequence and/or structural similar-
ity. Figure 8 shows sequences from the presumed origin
regions of 15 animal and human papillomaviruses. Each se-
quence was aligned for maximal homology with the El binding
region on BPV-1. While many of the papillomaviruses had IR
elements that were less perfect than the one in BPV-1 (i.e., had
more mismatches), we were able to define a symmetric con-
sensus sequence, T-RY--TTAA--RY-A, that was evident in all
15 of the papillomaviruses. This consensus sequence spanned
16 bp and resided entirely within the 18-bp IR region that was
sufficient for BPV-1 El binding to BPV-1 DNA. Within the 16
bp spanned by the consensus, only 10 nucleotide positions were
highly conserved, and these positions may represent the critical
nucleotides for El-DNA interactions. A point mutational
analysis of this region is in progress to investigate this possi-
bility.
DISCUSSION
Previous studies have shown that the BPV-1 El protein
binds to the origin of replication but have not clearly defined
BPV1: 7935 g a a t a a T t G T t g T T A A c a A T a A t c a c a c 17
BPV2: 7927 a a t a a T t G T t g T T A A c a A T a A t c a c a c
CRPV: 78t8 a t g g T tG T t C T A A c a A Ta Al t t a a g a 17
DPV: 8364 g a a t g a T I G T t g T T A A c a A T a' A c c a g a c 17
EEPV: 808 a a t g a T t G T t g TIT A A c a A Tc A c c a g a t 17
HPV1a: g a t t g T t G T t g T T A A c t A C c A t c a t t c 17
HPV5: 7733 g c t a a8 a g A C c g T T A A c g G T a A g t t g c a 14
HPV6b: 7892 t c c t t c T A T a g T T A A aA C a A c g 17
HPV8: 7647 9g9 a c c g T t A a c g T T A A g tt T c A t c a g t g 20
7921 T a T TA ta17HPV11: t c c t t c T t A T a c T T A A t a A C a A t c t t a g
7892 13HPV16: 8a a t a a T a A T a c T a A A c t A C a A t a a t t c 1
HPV18: t c a t t a a A C t t T T A A c a A T t g t a g t a t
HPV31: 7900 t c t t t T A T a c T T A A t a A T a A t a a t c t 15
HPV33: t t a t a T a A T a g T a A A C A T a A t g c c a a 1
HPV47: 7713 a c a a g a c a A C c g T T A A C g G T a A g t t t g c 14
T R Y - T T A A -R Y -A
FIG. 8. Homology among papillomaviruses in the BPV-1 El bind-
ing site region. Shown is a 28-bp region from the BPV-1 genome and
the comparable region from 14 other papillomaviruses. Nucleotide
numbers for the individual papillomavirus genomes are as indicated.
Within this 28-bp sequence, highly conserved regions are boxed. Below
is a consensus sequence derived from the boxed sequences. Nucleo-
tides within the boxed regions that conform to the consensus sequence
are in capital letters while nonconforming nucleotides are in lowercase
letters. CRPV, cottontail rabbit papillomavirus; DPV, deer papilloma-
virus; EEPV, European elk papillomavirus; HPV, human papilloma-
virus.
the sequences responsible for binding specificity. Using DNase
I and exonuclease III footprinting, we showed that El protec-
tion could extend over a 74-bp region of BPV-1 DNA. Within
this overall protected region, there was a strongly protected
core from nucleotides 7932 to 15. Examination of sequences
within the core protected region revealed the presence of
alternative, overlapping, IR elements. However, since both
overlapping IR elements were located within the boundaries of
the core nuclease-protected region, we could not distinguish
the relative importance of either element by the footprinting
studies. Subsequent experiments performed with double-
stranded oligonucleotides corresponding to each IR demon-
strated that sequences contained within the smaller, 18-bp IR
element were sufficient for El binding specificity: (i) El bound
efficiently to a self-ligated form of the 18-mer, but not to
similar-size oligos with comparable AT content but unrelated
sequence; (ii) ligated 18-mer effectively competed for El
binding to a 219-bp origin-containing fragment; and (iii) the
presence of a single copy of the 18-mer sequence in pUC18
fragments caused them to be bound by El while similar-size
fragments lacking the 18-mer were not bound.
While the BPV-1 18 bp IR element was sufficient to confer
El-specific binding, the El protein was not able to form a
stable complex with an isolated 18-mer sequence under our
immunoprecipitation binding conditions. El binding could
only be detected when the 18-bp sequence was contained
within a larger DNA fragment generated either through self-
ligation of the double-stranded oligonucleotide or by excision
of the cloned 18-mer along with flanking sequences. As the
flanking sequences for the cloned 18-mer were derived from
the vector and not BPV-1, this indicated that there was no
sequence specificity involved with this increased binding. From
the studies with the oligonucleotides and the cloned 18-mer,
we determined that the minimum sequence length required for
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detectable El binding was between 18 and 31 bp. Furthermore,
for fragments containing the 18-mer sequence, El binding
increased with increasing fragment size over the range from 31
to 55 bp. This increased binding with larger DNA substrates
was consistent with the footprinting experiments which de-
tected El-DNA interactions over an extended range. To-
gether, these results suggest that El contacts the DNA for a
significant distance beyond the 18-bp specificity element and
that these nonspecific sequence contacts are important for the
formation of stable El-DNA complexes. Additional BPV-1
specific sequences outside the 18-bp IR element did not appear
to contribute significantly to El-DNA binding since the 18-mer
embedded in a larger region of DNA was bound nearly as well
as a comparable fragment containing the 32-mer or a 105-bp
BPV-1 sequence.
How the El protein contacts the DNA over an extended
region is not yet clear. The overall length of the contact region
makes it unlikely that the distal interactions reflect binding of
a single molecule of El, unless there is significant deformation
of the DNA structure. While such deformation cannot be
excluded, a more likely possibility is that El is capable of
forming multimeric complexes as is the case for SV40 T
antigen. The symmetric nature of the binding region would be
consistent with binding of dimeric or larger oligomeric forms
of El. If binding does involve formation of multimers, the
failure to detect significant binding to either of the isolated
half-sites of the 18-bp IR suggests that binding and assembly
are highly cooperative.
Previous studies indicated that the overall origin regions
from BPV-1 and other animal and human papillomaviruses are
highly conserved (3, 28, 34). By focusing specifically on the
18-bp IR region, we identified a 16-bp symmetric consensus
element (T-RY--YTAA--RY-A) that has not been previously
described. This consensus element shows three degrees of
conservation: (i) six positions, the outer two nucleotides (po-
sitions 1 and 16), and the central four nucleotides (positions 7
to 10) are highly conserved and consist of specific nucleotides;
(ii) four positions are less stringent in that they are conserved
for either purines (nucleotides 3 and 13) or pyrimidines
(nucleotides 4 and 14) rather than specific nucleotides, and (iii)
the remaining positions (no. 2, 5, 6, 11, 12, and 15) are fairly
variable, with three different nucleotides being observed at
those positions. This sequence organization suggests that the
six highly conserved positions will be critical for binding of all
El proteins from different papillomaviruses, while the other
positions may contribute to papillomavirus type-specific El-
DNA interactions. We also noted that the 28-bp IR element in
BPV-1 was not well conserved among other papillomaviruses
(29). Lack of conservation in this larger IR is consistent with
the absence of sequences critical for El binding outside the
18-bp IR element.
A prediction from this conservation of the El binding region
is that the BPV-1 El protein might bind to heterologous
papillomavirus origins and might functionally substitute in
replication. Chiang et al. recently confirmed the second part of
this prediction recently by demonstrating that BPV-1 El could
substitute for the human papillomavirus type 11 (HPV-l 1) El
in replication in vivo (3). We have shown that the BPV-1 El
protein can bind to the homologous 18-bp IR in deer papillo-
mavirus, through binding to HPV-la DNA could not be
detected (29). Deer papillomavirus has exactly the same se-
quence as BPV-1 for the 18-bp IR region, but diverges outside
the boundaries of the 18-bp IR. Efficient binding of BPV-1 El
to deer papillomavirus supports the contention that only
sequences within the 18-bp IR are necessary for El binding
specificity. The HPV-la sequence, however, differs from
BPV-1 at four positions within the 18-bp region, three in
nonconserved positions and one at a conserved pyrimidine
position. The failure to detect BPV-1 El binding to HPV-la
DNA is consistent with decreased binding affinity due to one or
more of the nucleotide changes. Presumably, the cognate
HPV-la El would be more efficient at recognizing the HPV-la
sequences than is BPV-1 El. The results with HPV-la suggest
that HPV-11 would be an even poorer substrate for BPV-1 El
since it is more divergent with six nucleotide changes in the
18-bp region. If so, how could BPV-1 El substitute for HPV- I
El in the replication assay? We speculate that the presence of
the E2 protein in vivo compensates for weak El binding. The
E2 protein, which has been shown to enhance El's ability to
bind DNA (20, 23, 33), likely restored sufficient binding of
BPV-1 El to the HPV-11 origin to allow formation of func-
tional replication complexes. Such restoration is consistent
with the origin mutation studies of Spalholz et al. in which
origins that bound El poorly in the absence of E2 could still
replicate in vivo (23).
From our current studies and those of other groups, the
organization of the BPV-1 origin of replication is becoming
more clearly defined. It is apparent that the BPV-1 origin has
many features in common with the SV40 origin. Like SV40, the
functional BPV-1 origin contains an initiation protein (El)
binding region and an adjacent AT-rich sequence. In both
cases, the binding region contains a palindromic core element
with extensive protein-DNA contacts occurring beyond the
limits of the palindrome. Given the recent demonstration of El
helicase activity (20, 21), these similarities in DNA organiza-
tion and extended protein-DNA contact regions may reflect
similar mechanisms for protein assembly and subsequent un-
winding of origin DNA. However, while certain features are
clearly similar, there are also significant differences. Unlike
SV40, the BPV-1 origin also contains a binding site for a
second viral protein, E2TA (26). E2 enhances binding of El to
the origin, but it remains to be seen whether the enhancement
activity is merely a quantitative effect or whether it in fact
confers a qualitative difference on El function. In addition, the
SV40 origin contains a functionally significant static DNA
bend (25) while no such bend occurs in the BPV-1 origin (18).
Thus, it is clear that the BPV-1 system will provide an
alternative view of a eukaryotic origin. Identification of further
differences and similarities between these two systems should
continue to provide insight into fundamental aspects of repli-
cation initiation.
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